Spina bifida in infants of women treated with carbamazepine during pregnancy.
about
Common antiepileptic drugs in pregnancy in women with epilepsyCommon antiepileptic drugs in pregnancy in women with epilepsyVitamins for epilepsyIsotretinoin, pregnancies, abortions and birth defects: a population-based perspectiveA clinical study of 57 children with fetal anticonvulsant syndromesMood stabilizers in pregnancy and lactationBipolar disorder in womenEnsuring the safe and effective use of medications during pregnancy: planning and prevention through preconception careCarbamazepine and spina bifidaAdditional educational needs in children born to mothers with epilepsyRadial microbrain form of micrencephaly: possible association with carbamazepineFetal anticonvulsant syndrome and mutation in the maternal MTHFR geneImpact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.Clinical teratology.Medical genetics: 1. Clinical teratology in the age of genomics.Using current evidence in selecting antiepileptic drugs for use during pregnancy.Pregnancy outcome and neurodevelopment of children exposed in utero to psychoactive drugs: the Motherisk experience.Valproic acid use in psychiatry: issues in treating women of reproductive age.The offspring of epileptic mother.Special considerations for women with epilepsy.Update on new developments in the study of human teratogens.Teratogenic effects of antiepileptic drugsOxcarbazepine in the treatment of epilepsy.Septo-optic dysplasia as a manifestation of valproic acid embryopathy.Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder.Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for PsychopharmacologyRecommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects. Clinical Teratology Committee, Canadian College of Medical Geneticists.Managing bipolar disorder during pregnancy: weighing the risks and benefits.Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?Pathobiology and genetics of neural tube defects.Reproductive and metabolic disorders in women with epilepsy.Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology.Epidemiology, prenatal management, and prevention of neural tube defects.Current issues: women and bipolar disorder.Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth.Developmental neuropathology of environmental agents.Anticonvulsant Use in the Treatment of Bipolar Disorder: A Primer for Primary Care PhysiciansIs carbamazepine safe to take during pregnancy?The pharmacology of bipolar disorder during pregnancy and breastfeeding.Adverse drug effect-reactive metabolites and idiosyncratic drug reactions: Part I.
P2860
Q24187306-84418D67-DEE2-4965-A66F-581B6B5CF165Q24246634-4A23B044-C4A8-4679-8100-6DF15C4FD670Q24246947-5291EB6B-1AE7-4277-A669-09D8B8AA85F6Q24676609-E3877CBE-CE09-41E3-B77F-C7B2E339A5AFQ24681122-F797384D-921C-4D3F-978C-DA19070E088CQ26795394-4F3752F7-AE70-45A7-A68F-EFCD53E26274Q26795404-883EF21C-5DF1-404C-9F26-6CEB192ED528Q28199588-6FE0E579-DC82-408E-87D2-4C7E7127864AQ28333737-9E23A4FF-8A43-4026-AE4D-7A5854D19801Q28345141-EB43A279-7A3B-40F5-9807-2A805B95B13DQ28375387-6C674C81-0C56-4A9B-A761-E44858D7B895Q28376491-379BDEF7-5186-4514-B7F2-2FC812998756Q30443028-B60F26D2-AABD-476A-AE14-A992C28FE54CQ33581937-8F940A4D-B7C7-436D-ACDE-62E893D9AF83Q33895431-E2ED4900-EB4E-400C-AFDF-67C72C19156AQ33899323-1066A88D-FA2F-4FDE-AF3B-35F4FBCF24C5Q33921923-DD9F67E0-854C-4AAC-A698-AD769D74C5DBQ33922097-FCF4E6C6-9A16-4517-B8E6-E8D2947AC2ACQ33930531-C2840219-9288-45BF-8785-3E367826402FQ33999462-988B1F1B-F09C-4783-B828-09DF3B399AB5Q34123327-89554F1A-5001-4F84-B9B4-B8C5A6592E11Q34267151-3B445CC9-F69F-4B3D-B1C7-54287FBD70CDQ34445634-6B616925-683B-4DBE-A0F2-7B35E277E354Q34516439-5E8512D6-BAD1-4570-A042-B0C56CE015ABQ34547920-C19EAFFC-81B9-480B-84DF-06A4B099B52EQ34676317-E4DCEA3E-78D7-4A4A-B12A-AC79D2F9A904Q34707032-7C0987F4-37FA-412A-A879-8DF0F34C315FQ34708409-E8E78C6C-0C1A-4102-9B8D-6A3B398D313DQ34905287-12D67FB6-15E9-4637-9EEF-D9097D6E4350Q35147176-3E10E726-A650-404D-987A-5D5F56D54043Q35161328-1E4DCAA7-8B25-41C7-A343-10799C7F58BDQ35180787-9FECF0B6-310E-4B91-B508-2D18787FD498Q35183494-64FCDCC3-8CAD-4E55-9981-338282FA9773Q35236993-24305356-9BAB-44A8-8320-0D162C6FC83BQ35439268-08A0201F-6FAE-4475-8CD5-397192920562Q35639110-AA17F6B6-7E22-4998-9902-48A839313E6FQ35664266-046E5311-82BF-44A8-B165-F7AFBB56BF06Q35756326-D12A5A39-87C9-4991-B370-59CA179FC57CQ35779335-90D62DEC-D165-4BA5-BC94-1535373F5081Q35953632-FC071FA2-245E-4D0A-82CB-04A1AE47F2F7
P2860
Spina bifida in infants of women treated with carbamazepine during pregnancy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Spina bifida in infants of women treated with carbamazepine during pregnancy.
@en
Spina bifida in infants of women treated with carbamazepine during pregnancy.
@nl
type
label
Spina bifida in infants of women treated with carbamazepine during pregnancy.
@en
Spina bifida in infants of women treated with carbamazepine during pregnancy.
@nl
prefLabel
Spina bifida in infants of women treated with carbamazepine during pregnancy.
@en
Spina bifida in infants of women treated with carbamazepine during pregnancy.
@nl
P1476
Spina bifida in infants of women treated with carbamazepine during pregnancy.
@en
P2093
P304
P356
10.1056/NEJM199103073241006
P407
P577
1991-03-01T00:00:00Z